Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea
· Delayed Price · Currency is KRW
1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025
Kainos Medicine Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Aug '25 Aug 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 35,557 | 89,333 | 120,625 | 114,482 | 279,944 | 472,242 | |
| Market Cap Growth | -69.37% | -25.94% | 5.37% | -59.10% | -40.72% | - | |
| Enterprise Value | 37,375 | 89,178 | 109,730 | 91,314 | 275,139 | 460,327 | |
| Last Close Price | 1087.00 | 3170.00 | 4320.00 | 4100.00 | 11516.11 | 20402.55 | |
| PS Ratio | 37.87 | 151.32 | 451.25 | 880.46 | 168.40 | - | |
| PB Ratio | 4.54 | 10.91 | 6.32 | 3.40 | 15.42 | 29.00 | |
| P/TBV Ratio | 20.54 | 69.45 | 11.03 | 4.53 | 24.53 | 39.78 | |
| EV/Sales Ratio | 39.81 | 151.06 | 410.49 | 702.28 | 165.50 | - | |
| Debt / Equity Ratio | 0.03 | 0.06 | 0.02 | 0.12 | 0.79 | 0.69 | |
| Asset Turnover | 0.08 | 0.04 | 0.01 | 0.00 | 0.04 | - | |
| Quick Ratio | 2.43 | 1.74 | 9.16 | 6.20 | 1.56 | 33.07 | |
| Current Ratio | 3.00 | 1.93 | 9.50 | 6.41 | 1.67 | 35.41 | |
| Return on Equity (ROE) | -95.23% | -89.36% | -57.71% | -61.35% | -94.22% | -107.81% | |
| Return on Assets (ROA) | -46.11% | -49.26% | -35.04% | -24.95% | -18.28% | -29.08% | |
| Return on Capital (ROIC) | -50.64% | -55.47% | -36.78% | -28.78% | -23.33% | -35.84% | |
| Return on Capital Employed (ROCE) | -113.60% | -149.60% | -87.60% | -47.40% | -56.50% | -27.70% | |
| Earnings Yield | -28.54% | -13.65% | -12.63% | -13.87% | -5.79% | -2.42% | |
| FCF Yield | -17.96% | -10.87% | -15.10% | -11.46% | -3.98% | -1.83% | |
| Buyback Yield / Dilution | -8.89% | 0.27% | -17.14% | -12.49% | -4.59% | -5.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.